Snake BiteNCT07658885
Multicenter Application Verification and Effect Evaluation of Artificial Intelligence-Based Snake Species Identification System in the Diagnosis and Treatment of Snakebites
An observational study of Snake Bite, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.
Trial summary
This multicenter prospective observational study aims to develop and validate a deep learning-based artificial intelligence snake species identification system, and evaluate its clinical application efficacy in real-world emergency snakebite treatment scenarios. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Snake Bite
- What is being tested?
- SSRS system-assisted snake species identification
- How many people
- 400 participants
- Where
- 1 siteChina
- Study dates
- 20 Jun 2026to 31 Dec 2026
- How long will I take part?
- 30 Days
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: All snakebite patients included in this study were recruited from medical institutions in snakebite-endemic areas, primarily county-level and prefecture-level hospitals.
Who may be able to join
- Adult patients aged ≥18 years, regardless of gender
- Definite history of snake bite, with time from bite occurrence to first medical visit ≤24 hours
- The patient or eyewitness can provide digital images of the biting snake (taken by mobile phone, camera, etc.)
- Voluntarily sign the written informed consent form; for patients with impaired consciousness who cannot sign independently, their legal representative shall sign on their behalf, and a secondary confirmation shall be obtained after the patient regains consciousness
- Able to cooperate in completing follow-up assessments at discharge and 30 days after injury
Who cannot join
- 1. Unable to provide snake images, or images are severely blurred resulting in complete loss of key identification features 2. Snake species cannot be confirmed by the gold standard (no eyewitnesses, no typical clinical manifestations, cannot be clarified by expert panel consultation) 3. Medical visit exceeds 24 hours and the exact bite time and initial clinical manifestations cannot be determined 4. Complicated with end-stage malignant tumors, severe liver and kidney failure, or other underlying diseases that may significantly affect prognosis judgment 5. Refuse to sign the informed consent form or cannot cooperate in completing follow-up 6. Simultaneously participating in other clinical studies that may affect the results of this study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site
Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000
About this study
Official title: Development, Validation and Clinical Efficacy Evaluation of an AI-based Snake Species Identification System for Snakebite Treatment: a Multicenter Prospective Observational Study
This multicenter prospective observational study aims to develop and validate a deep learning-based artificial intelligence snake species identification system, and evaluate its clinical application efficacy in real-world emergency snakebite treatment scenarios. The primary research question it seeks to answer is:
In real clinical settings in Zhejiang Province, can the artificial intelligence snake species identification system accurately identify common indigenous snake species causing bites, and improve the accuracy and diagnostic efficiency of snake species judgment for physicians at different levels of medical institutions? This study will be conducted simultaneously in 10 medical institutions in Zhejiang Province. investigators will prospectively enroll patients with snakebite who present to the hospital between June 2026 and December 2026 and can provide photographs of the offending snakes. The snake species identification results of both attending physicians and the artificial intelligence system will be recorded synchronously, and the patients' clinical treatment and prognosis data will be collected. All patients will be followed up until 30 days after discharge.
Read the detailed description
- Methods 2.1 Study Design and Subjects This is a multicenter, phased model development and validation study conducted from May 15, 2025 to December 31, 2026 (corrected from the original typo "2006"). The study is implemented in 4 phases. This study was approved by the Institutional Review Board for Human Research, the Second Affiliated Hospital, Zhejiang University School of Medicine (Approval No.: (2026) Lun Shen Yan No. 0789). Informed consent was obtained from all patients in accordance with the Declaration of Helsinki.
2.2 Datasets
- Retrospective Dataset (Phases 1-2) Images were obtained from three sources: ① Public databases (https://www.inaturalist.org/home) and snake field guides; ② Photographs of offending snakes provided by patients or witnesses and collected by attending physicians in the Emergency Departments of 42 hospitals in Zhejiang Province from January 2021 to June 2026. After strict screening, a total of 15,680 images were finally included. The dataset was divided into three independent subsets (training set, validation set, and test set) at a ratio of 7:2:1 using stratified random sampling. Image Inclusion and Exclusion Criteria Inclusion criteria: Images clearly showing at least one key identifying feature of the snake body (head shape, scale texture, body color and pattern, tail characteristics, etc.); covering common clinical scenarios (grassland, rocks, farmland, indoor, clinical settings), shooting conditions (natural light, night lighting, low light on rainy days), shooting angles (front, side, back, close-up), and snake states (stationary, slight motion blur, partial occlusion); image resolution ≥ 1080×1920 pixels with no obvious post-processing traces. Exclusion criteria: ① Severely blurred images with completely obscured key identifying features; ② Duplicate images (same snake, same shooting scene); ③ Images with distorted features due to excessive post-processing (e.g., color adjustment, compositing); ④ Images with unidentifiable snake species.
- Prospective Dataset (Phases 3-4) From May 1 to December 31, 2026, photographs of snakes provided by snakebite patients at 10 cooperative hospitals were prospectively collected, and 400 images were selected for the multi-reader multi-case study in Phase 3. Concurrently, patients who could provide snake photographs at the above 10 hospitals were continuously enrolled, and clinical data were collected for the clinical validation in Phase 4. Inclusion criteria: Images clearly showing at least one key identifying feature of the snake body; covering common clinical shooting scenarios, lighting conditions, shooting angles, and snake states; identified snake species specimens.Exclusion criteria: Severely blurred images with completely obscured key identifying features; images with distorted features due to post-processing; unidentifiable snake species.
- Gold Standard Determination and Data Annotation A professional annotation team consisting of 2 senior emergency physicians with more than 10 years of experience in snakebite treatment and 1 herpetology researcher was established. A three-level annotation process of "double independent annotation - cross-checking - expert arbitration" was adopted to ensure annotation accuracy. When the two experts disagreed, a consensus meeting was held to resolve the differences, and the final label was jointly determined by both parties with detailed records.
2.3 Image Classification and Preprocessing
- Snake Classification Details Non-venomous snakes (44 species): Indotyphlops braminus, Xenopeltis hainanensis, Achalinus rufescens, Achalinus spinalis, Achalinus huangjietangi, Achalinus dehuaensis, Pareas chinensis, Pareas formosensis, Pareas fujianensis, Oligodon chinensis, Oligodon formosanus, Oligodon ornatus, Ptyas major, Ptyas dhumnades, Ptyas korros, Ptyas mucosa, Gonyosoma frenatum, Lycodon flavozonatus, Lycodon futsingensis, Lycodon liuchengchaoi, Lycodon ruhstrati, Lycodon rufozonatus, Euprepiophis mandarinus, Oreocryptophis porphyraceus, Elaphe bimaculata, Elaphe carinata, Elaphe taeniura, Dinodon rufozonatum, Calamaria septentrionalis, Calamaria pavimentata, Amphiesma stolatum, Amphiesma craspedogaster, Macropisthodon rudis, Xenochrophis flavipunctatus, Opisthotropis kuatunensis, Opisthotropis latouchii, Sinonatrix aequifasciata, Sinonatrix annularis, Sinonatrix percarinata, Plagiopholis styani, Pseudoxenodon macrops, Pseudoxenodon stejnegeri, Sibynophis chinensis. Venomous snakes (20 species): Highly venomous snakes (16 species): Azemiops feae, Protobothrops cornutus, Protobothrops mucrosquamatus, Deinagkistrodon acutus, Ovophis makazayazaya, Trimeresurus stejnegeri, Gloydius brevicaudus, Bungarus multicinctus, Naja atra, Ophiophagus hannah, Sinomicrurus kelloggi, Sinomicrurus annularis, Hydrophis cyanocinctus, Hydrophis melanocephalus, Pelamis platurus, Rhabdophis tigrinus (highly venomous but rarely envenomates humans); Mildly venomous snakes (4 species): Enhydris chinensis, Enhydris plumbea, Boiga kraepelini, Boiga multomaculata.
- Image Preprocessing
The open-source computer vision library OpenCV 4.8.0 was used to perform standardized preprocessing of images adapted to actual clinical shooting scenarios:
Images were uniformly resized to 640×640 pixels for size standardization, balancing model recognition accuracy and mobile deployment efficiency; 3×3 kernel Gaussian filtering was applied for denoising to remove image noise while preserving key snake identification features; Adaptive histogram equalization was used for illumination normalization to correct brightness differences under different shooting conditions; Data augmentation strategies including random rotation (±30°) and horizontal flipping were applied to the training set, combined with Mixup technology and GAN-synthesized images of rare snake species, to effectively improve the model's generalization ability.
2.4 AI Model Construction
Image segmentation and feature extraction: The SAM3 model was used to accurately segment the snake contour and blank the background to eliminate complex environmental interference; the lightweight and efficient ConvNeXt network was then used to extract fine-grained visual features.
Figure 1 Model architecture diagram: Shows the entire inference process. During the training phase, investigators froze the weight parameters of SAM3, and the Bayesian inference process did not participate in training, because the shooting locations of the images were difficult to obtain during dataset construction.
Cost-sensitive ensemble learning: A Stacking ensemble framework was constructed with SVM, Random Forest, Gradient Boosting, and XGBoost as base learners, and unbiased meta-features were generated through K-fold cross-validation; logistic regression was used as the meta-learner for nonlinear weighted fusion. Toxicity grading weights were introduced into the loss function to implement cost-sensitive learning, forcing the model to prioritize reducing the risk of missed diagnosis of venomous snakes.
Bayesian inference: Shooting location information was integrated during the inference phase. The training set class prior \(F_{\text{train}}(y)\) and geographic location prior \(F_{\text{loc}}(y)\) were combined through the Bayesian framework to correct the visual likelihood \(P_{\text{model}}(y|x)\), obtaining posterior classification probabilities more consistent with regional distribution characteristics and improving clinical robustness.
2.5 AI Model Evaluation Phase 1: Internal Validation Multi-dimensional evaluation of the Snake Species Recognition and Treatment Assistance System (SSRS) was performed on the test set, including 64-class snake species identification and binary classification of venomous/non-venomous snakes.
Phase 2: Cross-model Comparison Mainstream deep learning models and large language models (LLMs) were selected for cross-performance comparison on the internal test set of Phase 1 (ResNet50, MobileNetV3, YOLOv8, Doubao, Qwen, ChatGPT, Gemini, and Afu). The evaluation included 64-class snake species identification and binary classification of venomous/non-venomous snakes.
Phase 3: Multi-Reader Multi-Case (MRMC) Study To evaluate the improvement effect of SSRS on clinical snake species recognition ability, a fully cross-designed prospective MRMC study was conducted using 400 clinical snake photographs collected from June to December 2026. The study enrolled 4 senior experts in snakebite treatment and 16 emergency physicians from multiple primary hospitals.
The study was divided into two rounds:
Round 1: The SSRS system and 20 physicians independently completed the diagnosis of all images; a 4-week washout period was set to reduce recall bias.
Round 2: The 400 snake photographs were randomly sorted in the electronic reading system, and the 20 physicians re-interpreted the images based on the SSRS output results. The evaluation included 64-class snake species identification and binary classification of venomous/non-venomous snakes.
Readers were required to complete the diagnosis of a single image within 120 seconds. The 20 physicians were from different regions of Zhejiang Province, covering more than 80% of the primary snakebite treatment institutions in the province, including tertiary hospitals, county-level secondary hospitals, and township health centers; all held valid medical practitioner licenses, had ≥1 year of emergency department experience, and voluntarily signed informed consent and participated in the entire study.
Phase 4: Clinical Validation To evaluate the efficacy of SSRS in clinical scenarios, a prospective observational cohort study was adopted in this phase. A total of 400 snakebite patients collected from June to December 2026 were enrolled, and patient and physician information was recorded. Without interfering with clinical treatment, the identification results of both attending physicians and the SSRS system were recorded synchronously. The evaluation included 64-class snake species identification and binary classification of venomous/non-venomous snakes.
All data were collected using a standardized electronic case report form (eCRF):
Module Collected Fields
- Basic patient information Study ID (name), gender, age
- Attending physician information Hospital level, specialty, education background, years of work experience
- Snakebite event characteristics Original snake image; Bite location; Time since bite (minutes); Bite mark characteristics (number of bite marks, spacing in mm, standardized wound photographs)
- Identification and diagnosis Snake species/toxicity judged by attending physician; SSRS system output (snake species, venomous/non-venomous); Clinical symptoms
- Management and follow-up 2.6 Sample Size Calculation In the fully cross-designed MRMC study, based on the observed variance and effect size from the pilot study, with 20 readers preset (α=0.025, β=0.20, effect size=0.10), the minimum required sample size was calculated to be 116 cases. This study plans to enroll 400 cases.
2.7 Statistical Analysis Continuous variables are presented as mean ± standard deviation, and categorical variables are presented as numbers and percentages. The study constructed a "multi-class + binary" evaluation system: 64-class fine-grained snake classification was comprehensively evaluated using overall Accuracy, Macro-Precision, Macro-Recall, and Macro-F1; binary classification of venomous snakes was evaluated using Accuracy, Precision, Recall, and F1. The distribution characteristics of missed diagnosis of venomous snakes and misdiagnosis of non-venomous snakes were intuitively quantified using confusion matrices (P<0.05 was considered statistically significant).
- Conditions
- Snake Bite
- Being tested
- SSRS system-assisted snake species identification
- Keywords
- Snake Bite, Artificial Intelligence, Snake Species Identification, Deep Learning, Clinical Validation
- Medical subject headings
- Snake Bites
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SSRS system-assisted snake species identificationDiagnostic test
Without interfering with clinical treatment, simultaneously record the physician's assessment and the identification results from the SSRS system.
What is being measured
The primary outcome is the main question the study is designed to answer.
Snake species identification (64-class classification) and venomous/non-venomous snake discrimination (binary classification)
Measured: From enrollment to the end of treatment at 30 days
Secondary outcomes (2)
Consistency between physicians' judgments and AI results(%)
Measured: From enrollment to the end of treatment at 30 days
median time from hospital presentation to definitive snake species identification(hour)
Measured: 72 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jun 2026
- Study start20 Jun 2026 (estimated)
- Primary completion20 Jun 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Snake BiteStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 400 participants (estimated)
- Target duration
- 30 Days
Sponsor and investigators
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Sponsor type
- University, hospital or other
- Collaborators
- The Central Hospital of Lishui City
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07658885
- Sponsor's protocol ID
- 2026-0559
- Status last verified
- Jun 2026
- First submitted
- 5 Jun 2026
- Last updated
- 22 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- Individual data sharing
- Yes: all IPD that underlie results in a publication
Publications
Binta Islam S, Valles D, Hibbitts TJ, Ryberg WA, Walkup DK, Forstner MRJ. Animal Species Recognition with Deep Convolutional Neural Networks from Ecological Camera Trap Images. Animals (Basel). 2023 May 2;13(9):1526. doi: 10.3390/ani13091526.
PubMed 37174563Zhang J, Chen X, Song A, Li X. Artificial intelligence-based snakebite identification using snake images, snakebite wound images, and other modalities of information: A systematic review. Int J Med Inform. 2023 May;173:105024. doi: 10.1016/j.ijmedinf.2023.105024. Epub 2023 Feb 24.
PubMed 36848781Aga AM, Mulugeta D, Motuma A, Wakitole B, Muleta D, Ferede H, Teferi Z, Tadesse S, Abebe T, Alemayehu F, Dube D, Oljira S, Alemu A, Gebrewold G, Woldemariyam FT, Nigussie D. Health professionals' knowledge, attitudes, and practices in snakebite management: A study from high-burden areas in the Afar Region, Ethiopia. PLoS Negl Trop Dis. 2025 Nov 20;19(11):e0013713. doi: 10.1371/journal.pntd.0013713. eCollection 2025 Nov.
PubMed 41264600Abraham SV, Paul S, Mathew D, Rajeev PC, Paul MV, Davis C. Challenges in Snakebite Management in India: Insights from a Physician Survey with Special Focus on Kerala and treatment of bites by Hump-nosed Pit Vipers (Hypnale spp.). Wilderness Environ Med. 2025 Mar;36(1):76-88. doi: 10.1177/10806032241290800. Epub 2024 Nov 18.
PubMed 39552571Rao S, Reghu N, Nair BG, Vanuopadath M. The Role of Snake Venom Proteins in Inducing Inflammation Post-Envenomation: An Overview on Mechanistic Insights and Treatment Strategies. Toxins (Basel). 2024 Dec 2;16(12):519. doi: 10.3390/toxins16120519.
PubMed 39728777Shen Y, Hu S, Bao S, Tu M. Clinical characteristics of snakebite patients attending a tertiary hospital in Hangzhou, southeast China. Trans R Soc Trop Med Hyg. 2024 Apr 6;118(4):287-292. doi: 10.1093/trstmh/trad087.
PubMed 38073610Yan S, Fu W, Yan Z, Hu Y, Song X, Wang J, Hao W, He L, Chen Y, Diane M, Souare IS, Guo W, Bin W, Ma Y, Han X, Lv C. Clinical epidemiology of snakebite envenoming in hospitals 11 provinces of Yangtze River Basin and southern regions of China: A retrospective hospital-based analysis. PLoS Negl Trop Dis. 2026 Apr 27;20(4):e0013247. doi: 10.1371/journal.pntd.0013247. eCollection 2026 Apr.
PubMed 42044109Nyarko E, Atubiga IA, Siame ET, Gutierrez JM, Fernandez EA. Healthcare workers' priorities of WHO snakebite strategic objectives for the control and prevention of snakebite envenoming in Ghana: A machine learning statistical design of experiment modeling. PLoS Negl Trop Dis. 2025 Jul 10;19(7):e0013295. doi: 10.1371/journal.pntd.0013295. eCollection 2025 Jul.
PubMed 40638704
Study at a glance
From the registry record, last updated by the sponsor on 22 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development, Validation and Clinical Efficacy Evaluation of an AI-based Snake Species Identification System for Snakebite Treatment: a Multicenter Prospective Observational Study
- ClinicalTrials.gov ID
- NCT07658885
- Acronym / sponsor ID
- 2026-0559
- Conditions
- Snake Bite
- Keywords
- Snake Bite, Artificial Intelligence, Snake Species Identification, Deep Learning, Clinical Validation
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of MedicineUniversity, hospital or other
- Collaborators
- The Central Hospital of Lishui City
- Study start
- 20 Jun 2026 (estimated)
- Primary completion
- 20 Jun 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 22 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This multicenter prospective observational study aims to develop and validate a deep learning-based artificial intelligence snake species identification system, and evaluate its clinical application efficacy in real-world emergency snakebite treatment scenarios. The primary research question it seeks to answer is:
In real clinical settings in Zhejiang Province, can the artificial intelligence snake species identification system accurately identify common indigenous snake species causing bites, and improve the accuracy and diagnostic efficiency of snake species judgment for physicians at different levels of medical institutions? This study will be conducted simultaneously in 10 medical institutions in Zhejiang Province. investigators will prospectively enroll patients with snakebite who present to the hospital between June 2026 and December 2026 and can provide photographs of the offending snakes. The snake species identification results of both attending physicians and the artificial intelligence system will be recorded synchronously, and the patients' clinical treatment and prognosis data will be collected. All patients will be followed up until 30 days after discharge.
Detailed description
- Methods 2.1 Study Design and Subjects This is a multicenter, phased model development and validation study conducted from May 15, 2025 to December 31, 2026 (corrected from the original typo "2006"). The study is implemented in 4 phases. This study was approved by the Institutional Review Board for Human Research, the Second Affiliated Hospital, Zhejiang University School of Medicine (Approval No.: (2026) Lun Shen Yan No. 0789). Informed consent was obtained from all patients in accordance with the Declaration of Helsinki.
2.2 Datasets
- Retrospective Dataset (Phases 1-2) Images were obtained from three sources: ① Public databases (https://www.inaturalist.org/home) and snake field guides; ② Photographs of offending snakes provided by patients or witnesses and collected by attending physicians in the Emergency Departments of 42 hospitals in Zhejiang Province from January 2021 to June 2026. After strict screening, a total of 15,680 images were finally included. The dataset was divided into three independent subsets (training set, validation set, and test set) at a ratio of 7:2:1 using stratified random sampling. Image Inclusion and Exclusion Criteria Inclusion criteria: Images clearly showing at least one key identifying feature of the snake body (head shape, scale texture, body color and pattern, tail characteristics, etc.); covering common clinical scenarios (grassland, rocks, farmland, indoor, clinical settings), shooting conditions (natural light, night lighting, low light on rainy days), shooting angles (front, side, back, close-up), and snake states (stationary, slight motion blur, partial occlusion); image resolution ≥ 1080×1920 pixels with no obvious post-processing traces. Exclusion criteria: ① Severely blurred images with completely obscured key identifying features; ② Duplicate images (same snake, same shooting scene); ③ Images with distorted features due to excessive post-processing (e.g., color adjustment, compositing); ④ Images with unidentifiable snake species.
- Prospective Dataset (Phases 3-4) From May 1 to December 31, 2026, photographs of snakes provided by snakebite patients at 10 cooperative hospitals were prospectively collected, and 400 images were selected for the multi-reader multi-case study in Phase 3. Concurrently, patients who could provide snake photographs at the above 10 hospitals were continuously enrolled, and clinical data were collected for the clinical validation in Phase 4. Inclusion criteria: Images clearly showing at least one key identifying feature of the snake body; covering common clinical shooting scenarios, lighting conditions, shooting angles, and snake states; identified snake species specimens.Exclusion criteria: Severely blurred images with completely obscured key identifying features; images with distorted features due to post-processing; unidentifiable snake species.
- Gold Standard Determination and Data Annotation A professional annotation team consisting of 2 senior emergency physicians with more than 10 years of experience in snakebite treatment and 1 herpetology researcher was established. A three-level annotation process of "double independent annotation - cross-checking - expert arbitration" was adopted to ensure annotation accuracy. When the two experts disagreed, a consensus meeting was held to resolve the differences, and the final label was jointly determined by both parties with detailed records.
2.3 Image Classification and Preprocessing
- Snake Classification Details Non-venomous snakes (44 species): Indotyphlops braminus, Xenopeltis hainanensis, Achalinus rufescens, Achalinus spinalis, Achalinus huangjietangi, Achalinus dehuaensis, Pareas chinensis, Pareas formosensis, Pareas fujianensis, Oligodon chinensis, Oligodon formosanus, Oligodon ornatus, Ptyas major, Ptyas dhumnades, Ptyas korros, Ptyas mucosa, Gonyosoma frenatum, Lycodon flavozonatus, Lycodon futsingensis, Lycodon liuchengchaoi, Lycodon ruhstrati, Lycodon rufozonatus, Euprepiophis mandarinus, Oreocryptophis porphyraceus, Elaphe bimaculata, Elaphe carinata, Elaphe taeniura, Dinodon rufozonatum, Calamaria septentrionalis, Calamaria pavimentata, Amphiesma stolatum, Amphiesma craspedogaster, Macropisthodon rudis, Xenochrophis flavipunctatus, Opisthotropis kuatunensis, Opisthotropis latouchii, Sinonatrix aequifasciata, Sinonatrix annularis, Sinonatrix percarinata, Plagiopholis styani, Pseudoxenodon macrops, Pseudoxenodon stejnegeri, Sibynophis chinensis. Venomous snakes (20 species): Highly venomous snakes (16 species): Azemiops feae, Protobothrops cornutus, Protobothrops mucrosquamatus, Deinagkistrodon acutus, Ovophis makazayazaya, Trimeresurus stejnegeri, Gloydius brevicaudus, Bungarus multicinctus, Naja atra, Ophiophagus hannah, Sinomicrurus kelloggi, Sinomicrurus annularis, Hydrophis cyanocinctus, Hydrophis melanocephalus, Pelamis platurus, Rhabdophis tigrinus (highly venomous but rarely envenomates humans); Mildly venomous snakes (4 species): Enhydris chinensis, Enhydris plumbea, Boiga kraepelini, Boiga multomaculata.
- Image Preprocessing
The open-source computer vision library OpenCV 4.8.0 was used to perform standardized preprocessing of images adapted to actual clinical shooting scenarios:
Images were uniformly resized to 640×640 pixels for size standardization, balancing model recognition accuracy and mobile deployment efficiency; 3×3 kernel Gaussian filtering was applied for denoising to remove image noise while preserving key snake identification features; Adaptive histogram equalization was used for illumination normalization to correct brightness differences under different shooting conditions; Data augmentation strategies including random rotation (±30°) and horizontal flipping were applied to the training set, combined with Mixup technology and GAN-synthesized images of rare snake species, to effectively improve the model's generalization ability.
2.4 AI Model Construction
Image segmentation and feature extraction: The SAM3 model was used to accurately segment the snake contour and blank the background to eliminate complex environmental interference; the lightweight and efficient ConvNeXt network was then used to extract fine-grained visual features.
Figure 1 Model architecture diagram: Shows the entire inference process. During the training phase, investigators froze the weight parameters of SAM3, and the Bayesian inference process did not participate in training, because the shooting locations of the images were difficult to obtain during dataset construction.
Cost-sensitive ensemble learning: A Stacking ensemble framework was constructed with SVM, Random Forest, Gradient Boosting, and XGBoost as base learners, and unbiased meta-features were generated through K-fold cross-validation; logistic regression was used as the meta-learner for nonlinear weighted fusion. Toxicity grading weights were introduced into the loss function to implement cost-sensitive learning, forcing the model to prioritize reducing the risk of missed diagnosis of venomous snakes.
Bayesian inference: Shooting location information was integrated during the inference phase. The training set class prior \(F_{\text{train}}(y)\) and geographic location prior \(F_{\text{loc}}(y)\) were combined through the Bayesian framework to correct the visual likelihood \(P_{\text{model}}(y|x)\), obtaining posterior classification probabilities more consistent with regional distribution characteristics and improving clinical robustness.
2.5 AI Model Evaluation Phase 1: Internal Validation Multi-dimensional evaluation of the Snake Species Recognition and Treatment Assistance System (SSRS) was performed on the test set, including 64-class snake species identification and binary classification of venomous/non-venomous snakes.
Phase 2: Cross-model Comparison Mainstream deep learning models and large language models (LLMs) were selected for cross-performance comparison on the internal test set of Phase 1 (ResNet50, MobileNetV3, YOLOv8, Doubao, Qwen, ChatGPT, Gemini, and Afu). The evaluation included 64-class snake species identification and binary classification of venomous/non-venomous snakes.
Phase 3: Multi-Reader Multi-Case (MRMC) Study To evaluate the improvement effect of SSRS on clinical snake species recognition ability, a fully cross-designed prospective MRMC study was conducted using 400 clinical snake photographs collected from June to December 2026. The study enrolled 4 senior experts in snakebite treatment and 16 emergency physicians from multiple primary hospitals.
The study was divided into two rounds:
Round 1: The SSRS system and 20 physicians independently completed the diagnosis of all images; a 4-week washout period was set to reduce recall bias.
Round 2: The 400 snake photographs were randomly sorted in the electronic reading system, and the 20 physicians re-interpreted the images based on the SSRS output results. The evaluation included 64-class snake species identification and binary classification of venomous/non-venomous snakes.
Readers were required to complete the diagnosis of a single image within 120 seconds. The 20 physicians were from different regions of Zhejiang Province, covering more than 80% of the primary snakebite treatment institutions in the province, including tertiary hospitals, county-level secondary hospitals, and township health centers; all held valid medical practitioner licenses, had ≥1 year of emergency department experience, and voluntarily signed informed consent and participated in the entire study.
Phase 4: Clinical Validation To evaluate the efficacy of SSRS in clinical scenarios, a prospective observational cohort study was adopted in this phase. A total of 400 snakebite patients collected from June to December 2026 were enrolled, and patient and physician information was recorded. Without interfering with clinical treatment, the identification results of both attending physicians and the SSRS system were recorded synchronously. The evaluation included 64-class snake species identification and binary classification of venomous/non-venomous snakes.
All data were collected using a standardized electronic case report form (eCRF):
Module Collected Fields
- Basic patient information Study ID (name), gender, age
- Attending physician information Hospital level, specialty, education background, years of work experience
- Snakebite event characteristics Original snake image; Bite location; Time since bite (minutes); Bite mark characteristics (number of bite marks, spacing in mm, standardized wound photographs)
- Identification and diagnosis Snake species/toxicity judged by attending physician; SSRS system output (snake species, venomous/non-venomous); Clinical symptoms
- Management and follow-up 2.6 Sample Size Calculation In the fully cross-designed MRMC study, based on the observed variance and effect size from the pilot study, with 20 readers preset (α=0.025, β=0.20, effect size=0.10), the minimum required sample size was calculated to be 116 cases. This study plans to enroll 400 cases.
2.7 Statistical Analysis Continuous variables are presented as mean ± standard deviation, and categorical variables are presented as numbers and percentages. The study constructed a "multi-class + binary" evaluation system: 64-class fine-grained snake classification was comprehensively evaluated using overall Accuracy, Macro-Precision, Macro-Recall, and Macro-F1; binary classification of venomous snakes was evaluated using Accuracy, Precision, Recall, and F1. The distribution characteristics of missed diagnosis of venomous snakes and misdiagnosis of non-venomous snakes were intuitively quantified using confusion matrices (P<0.05 was considered statistically significant).
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Target follow-up
- 30 Days
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- All snakebite patients included in this study were recruited from medical institutions in snakebite-endemic areas, primarily county-level and prefecture-level hospitals.
Key inclusion criteria (5 listed)
- Adult patients aged ≥18 years, regardless of gender
- Definite history of snake bite, with time from bite occurrence to first medical visit ≤24 hours
- The patient or eyewitness can provide digital images of the biting snake (taken by mobile phone, camera, etc.)
- Voluntarily sign the written informed consent form; for patients with impaired consciousness who cannot sign independently, their legal representative shall sign on their behalf, and a secondary confirmation shall be obtained after the patient regains consciousness
- Able to cooperate in completing follow-up assessments at discharge and 30 days after injury
Key exclusion criteria (1 listed)
- 1. Unable to provide snake images, or images are severely blurred resulting in complete loss of key identification features 2. Snake species cannot be confirmed by the gold standard (no eyewitnesses, no typical clinical manifestations, cannot be clarified by expert panel consultation) 3. Medical visit exceeds 24 hours and the exact bite time and initial clinical manifestations cannot be determined 4. Complicated with end-stage malignant tumors, severe liver and kidney failure, or other underlying diseases that may significantly affect prognosis judgment 5. Refuse to sign the informed consent form or cannot cooperate in completing follow-up 6. Simultaneously participating in other clinical studies that may affect the results of this study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SSRS system-assisted snake species identificationWithout interfering with clinical treatment, simultaneously record the physician's assessment and the identification results from the SSRS system. | Diagnostic test | – |
Primary outcome
Snake species identification (64-class classification) and venomous/non-venomous snake discrimination (binary classification)
Time frame: From enrollment to the end of treatment at 30 days
2 secondary outcomes
Consistency between physicians' judgments and AI results(%)
Time frame: From enrollment to the end of treatment at 30 days
median time from hospital presentation to definitive snake species identification(hour)
Time frame: 72 hours
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jun 2026.
- Results publication: PubMed 37174563Binta Islam S, Valles D, Hibbitts TJ, Ryberg WA, Walkup DK, Forstner MRJ. Animal Species Recognition with Deep Convolutional Neural Networks from Ecological Camera Trap Images. Animals (Basel). 2023 May 2;13(9):1526. doi: 10.3390/ani13091526.
- Results publication: PubMed 36848781Zhang J, Chen X, Song A, Li X. Artificial intelligence-based snakebite identification using snake images, snakebite wound images, and other modalities of information: A systematic review. Int J Med Inform. 2023 May;173:105024. doi: 10.1016/j.ijmedinf.2023.105024. Epub 2023 Feb 24.
- Results publication: PubMed 41264600Aga AM, Mulugeta D, Motuma A, Wakitole B, Muleta D, Ferede H, Teferi Z, Tadesse S, Abebe T, Alemayehu F, Dube D, Oljira S, Alemu A, Gebrewold G, Woldemariyam FT, Nigussie D. Health professionals' knowledge, attitudes, and practices in snakebite management: A study from high-burden areas in the Afar Region, Ethiopia. PLoS Negl Trop Dis. 2025 Nov 20;19(11):e0013713. doi: 10.1371/journal.pntd.0013713. eCollection 2025 Nov.
- Results publication: PubMed 39552571Abraham SV, Paul S, Mathew D, Rajeev PC, Paul MV, Davis C. Challenges in Snakebite Management in India: Insights from a Physician Survey with Special Focus on Kerala and treatment of bites by Hump-nosed Pit Vipers (Hypnale spp.). Wilderness Environ Med. 2025 Mar;36(1):76-88. doi: 10.1177/10806032241290800. Epub 2024 Nov 18.
- Results publication: PubMed 39728777Rao S, Reghu N, Nair BG, Vanuopadath M. The Role of Snake Venom Proteins in Inducing Inflammation Post-Envenomation: An Overview on Mechanistic Insights and Treatment Strategies. Toxins (Basel). 2024 Dec 2;16(12):519. doi: 10.3390/toxins16120519.
- Results publication: PubMed 38073610Shen Y, Hu S, Bao S, Tu M. Clinical characteristics of snakebite patients attending a tertiary hospital in Hangzhou, southeast China. Trans R Soc Trop Med Hyg. 2024 Apr 6;118(4):287-292. doi: 10.1093/trstmh/trad087.
- Results publication: PubMed 42044109Yan S, Fu W, Yan Z, Hu Y, Song X, Wang J, Hao W, He L, Chen Y, Diane M, Souare IS, Guo W, Bin W, Ma Y, Han X, Lv C. Clinical epidemiology of snakebite envenoming in hospitals 11 provinces of Yangtze River Basin and southern regions of China: A retrospective hospital-based analysis. PLoS Negl Trop Dis. 2026 Apr 27;20(4):e0013247. doi: 10.1371/journal.pntd.0013247. eCollection 2026 Apr.
- Results publication: PubMed 40638704Nyarko E, Atubiga IA, Siame ET, Gutierrez JM, Fernandez EA. Healthcare workers' priorities of WHO snakebite strategic objectives for the control and prevention of snakebite envenoming in Ghana: A machine learning statistical design of experiment modeling. PLoS Negl Trop Dis. 2025 Jul 10;19(7):e0013295. doi: 10.1371/journal.pntd.0013295. eCollection 2025 Jul.
- Individual participant dataSharing planned: Yes. all IPD that underlie results in a publication
Related trials for Snake Bite
RecruitingObservational study
Mapping Snakebite Risk in Ghana and Rwanda
Snakebite, Snake Envenomation
RecruitingObservational study
Predictive Accuracy of the Snakebite Severity Score (SSS) in Identifying Syndrome-Specific Core Outcome Parameters Among Envenomated Patients Presenting to the Emergency Department
Snake Bite
Not yet recruitingObservational study
Point-of-care Ultrasound in the Assessment of Snake Bite
Rattlesnake Bite (Diagnosis)
RecruitingObservational study
Polyvalent Antivenom (Premium-PANAF) for Snakebite Envenoming in Ethiopia
Snake Envenomation
Not yet recruitingPhase 2
Trial of Oral Community SVMP INhibitors for Snakebite
Snakebite
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Snake Bite, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 22 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Snake species identification (64-class classification) and venomous/non-venomous snake discrimination (binary classification) (time frame: From enrollment to the end of treatment at 30 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07658885, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2026.